Microarray analysis in gastric cancer: A review

World Journal of Gastroenterology

Volumn 20, Issue 34, 2014, Pages 11972-11976

  D'Angelo, Giovanna ^a   Di Rienzo, Teresa ^a   Ojetti, Veronica ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Array; Chemotherapy; Gastric cancer; Genes; Prognosis

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER PROGNOSIS; DNA MICROARRAY; EARLY DIAGNOSIS; GENE EXPRESSION; GENETIC TRAIT; HUMAN; METASTASIS; MICROARRAY ANALYSIS; REVIEW; RISK FACTOR; STOMACH CANCER; ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; STOMACH NEOPLASMS;

ANIMALS; EARLY DETECTION OF CANCER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84909640386     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i34.11972     Document Type: Review

References (38)

1. Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, Renehan AG, Forman D, Soerjomataram I. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur J Cancer 2013 Oct 8; Epub ahead of print [PMID: 24120180 DOI: 10.1016/j.ejca.2013.09.002]
2. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362 [PMID: 16489633]
3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403 [PMID: 23485231 DOI: 10.1016/j.ejca.2012.12.027]
4. Paoletti X, Oba K, Bang YJ, Bleiberg H, Boku N, Bouché O, Catalano P, Fuse N, Michiels S, Moehler M, Morita S, Ohashi Y, Ohtsu A, Roth A, Rougier P, Sakamoto J, Sargent D, Sasako M, Shitara K, Thuss-Patience P, Van Cutsem E, Burzykowski T, Buyse M. Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. J Natl Cancer Inst 2013; 105: 1667-1670 [PMID: 24108811 DOI: 10.1093/jnci/djt269]
5. de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 2013; 42: 219-240 [PMID: 23639638 DOI: 10.1016/j.gtc.2013.01.003]
6. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006; 20: 633-649 [PMID: 16997150 DOI: 10.1016/j.bpg.2006.04.008]
7. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131 [PMID: 1891020]
8. Lo SS, Wu CW, Hsieh MC, Kuo HS, Lui WY, P'Eng FK. Relationship between age and clinical characteristics of patients with gastric cancer. J Gastroenterol Hepatol 1996; 11: 511-514 [PMID: 8792301 DOI: 10.1111/j.1440-1746.1996.tb01693.x]
9. Cid TP, Fernández MC, Benito Martínez S, Jones NL. Pathogenesis of Helicobacter pylori infection. Helicobacter 2013; 18 Suppl 1: 12-17 [PMID: 24011239 DOI: 10.1111/hel.12076]
10. Cover TL, Peek RM. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes 2013; 4: 482-493 [PMID: 23989802 DOI: 10.4161/gmic.26262]
11. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L. The case for early detection. Nat Rev Cancer 2003; 3: 243-252 [PMID: 12671663 DOI: 10.1038/nrc1041]
12. Turner ES, Turner JR. Expanding the Lauren classification: a new gastric cancer subtype? Gastroenterology 2013; 145: 505-508 [PMID: 23891604 DOI: 10.1053/j.gastro.2013.07.019]
13. Ohta H, Noguchi Y, Takagi K, Nishi M, Kajitani T, Kato Y. Early gastric carcinoma with special reference to macroscopic classification. Cancer 1987; 60: 1099-1106 [PMID: 3607727 DOI: 10.1002/1097-0142(19870901)60:5<1099::AID]
14. Weber WA, Ott K. Imaging of esophageal and gastric cancer. Semin Oncol 2004; 31: 530-541 [PMID: 15297944 DOI: 10.1053/j.seminoncol.2004.04.016]
15. Genta RM. Screening for gastric cancer: does it make sense? Aliment Pharmacol Ther 2004; 20 Suppl 2: 42-47 [PMID: 15335412 DOI: 10.1111/j.1365-2036.2004.02039.x]
16. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, Pinto E. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57: 55-62 [PMID: 10394126]
17. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, Iwashige H, Tokushige M, Watanabe T, Takao S, Aikou T. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001; 32: 41-44 [PMID: 11154168 DOI: 10.1097/00004836-200101000-00010]
18. Gaspar MJ, Arribas I, Coca MC, Díez-Alonso M. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 2001; 22: 318-322 [PMID: 11553862 DOI: 10.1159/000050633]
19. Ebert MP, Röcken C. Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol 2006; 18: 847-853 [PMID: 16825900 DOI: 10.1097/00042737-200608000-00007]
20. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996; 14: 457-460 [PMID: 8944026]
21. Peddanna N, Holt S, Verma RS. Genetics of gastric cancer. Anticancer Res 1995; 15: 2055-2064 [PMID: 8572602]
22. Corso G, Seruca R, Roviello F. Gastric cancer carcinogenesis and tumor progression. Ann Ital Chir 2012; 83: 172-176 [PMID: 22595727]
23. Tian MM, Sun Y, Li ZW, Wu Y, Zhao AL, Li JY. Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J Gastroenterol 2012; 18: 368-374 [PMID: 22294843 DOI: 10.3748/wjg.v18.i4.368]
24. Yang S, Zhao Z, Wu R, Lu H, Zhang X, Huan C, Wang C, Wu X, Guan G. Expression and biological relationship of vascular endothelial growth factor-A and matrix metalloproteinase-9 in gastric carcinoma. J Int Med Res 2011; 39: 2076-2085 [PMID: 22289522 DOI: 10.1177/147323001103900603]
25. Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagström J, Haglund C. MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol 2010; 31: 149-155 [PMID: 20300917 DOI: 10.1007/s13277-010-0020-1]
26. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K, Takano Y. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 2006; 26: 3579-3583 [PMID: 17094486]
27. Huang SM, Chen TS, Chiu CM, Chang LK, Liao KF, Tan HM, Yeh WL, Chang GR, Wang MY, Lu DY. GDNF increases cell motility in human colon cancer through VEGFVEGFR1 interaction. Endocr Relat Cancer 2014; 21: 73-84 [PMID: 24165321 DOI: 10.1530/ERC-13-0351]
28. Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, Fukayama M, Kodama T, Aburatani H. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 2002; 62: 233-240 [PMID: 11782383]
29. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, Chan AS, Law S, Troyanskaya OG, Wong J, So S, Botstein D, Brown PO. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 2003; 14: 3208-3215 [PMID: 12925757 DOI: 10.1091/mbc.E02-12-0833]
30. Ojetti V, Persiani R, Cananzi FC, Sensi C, Piscaglia AC, Saulnier N, Biondi A, Gasbarrini A, D'Ugo D. cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. World J Surg 2014; 38: 2058-2064 [PMID: 24696059 DOI: 10.1007/s00268-014-2529-8]
31. El-Rifai W, Frierson HF, Harper JC, Powell SM, Knuutila S. Expression profiling of gastric adenocarcinoma using cDNA array. Int J Cancer 2001; 92: 832-838 [PMID: 11351303 DOI: 10.1002/ijc.1264]
32. Im S, Yoo C, Jung JH, Choi HJ, Yoo J, Kang CS. Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis. Int J Med Sci 2013; 10: 133-140 [PMID: 23329884 DOI: 10.7150/ijms.5500]
33. Jin Y, Da W. Screening of key genes in gastric cancer with DNA microarray analysis. Eur J Med Res 2013; 18: 37 [PMID: 24093889 DOI: 10.1186/2047-783X-18-37]
34. Sanford M. Trastuzumab: a review of its use in HER2-positive advanced gastric cancer. Drugs 2013; 73: 1605-1615 [PMID: 24057416 DOI: 10.1007/s40265-013-0119-y]
35. Meza-Junco J, Sawyer MB. Metastatic gastric cancer - focus on targeted therapies. Biologics 2012; 6: 137-146 [PMID: 22807624 DOI: 10.2147/BTT.S23917]
36. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376: 687-697 [PMID: 20728210 DOI: 10.1016/S0140-6736(10)61121]
37. Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H, Kelsen DP. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res 2011; 17: 2693-2701 [PMID: 21430069 DOI: 10.1158/1078-0432.CCR-10-2203]
38. Cho JY. Molecular diagnosis for personalized target therapy in gastric cancer. J Gastric Cancer 2013; 13: 129-135 [PMID: 24156032]